FindTrial
Sign In

Muscle function and how it affects function in heart failure

Prevalence of sarcopenia and its association with function and mobility in acute decompensated heart failure

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/04/024722
Enrollment
110
Registered
2020-04-20
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I504- Combined systolic (congestive) anddiastolic (congestive) heart failure

Interventions

None listed

Sponsors

Lakshman Iyer
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ADHF in-patients ( Framingham criteria ) Diagnosed HF ( >1 year ) Age â?? no limit New York Heart Association (NYHA) class II â?? IV Corrected vision / normal vision Functionally ambulant

Exclusion criteria

Exclusion criteria: Soft tissue injury in the past 1-3 months Fracture in lower extremities in the past 3-6 months Neurological conditions causing significant impairments like stroke Medically unstable patients (acute MI) Any medical disorder which precludes participation Short Blessed Test score > 7

Design outcomes

Primary

MeasureTime frame
SARCOPENIA Using the European Working Group on Sarcopenia in Older People (EWGSOP2) Algorithm consisting of 1. Short Physical Performance Battery 2. Timed Up and Go test 3. SARC-F questionnaire 4. Bioelectrical Impedance Analysis Timepoint: On the date of discharge—

Secondary

MeasureTime frame
1.6 Minute Walk Test 2.Mobility Disability Scale 3.Fried Frailty Index Timepoint: On the date of discharge ;1.Major Adverse Cardiovascular Events 2.Mobility Disability ScaleTimepoint: 1,3 and 6 months—

Countries

India

Contacts

Public ContactDr Vaishali K

Manipal Academy of Higher Education

abraham.babu@manipal.edu9742502838

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026